Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88369665
Filing Date:04/03/2019
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word "Vyndamax" with three curved lines, each tapering to a point, that form a flare design above and to the right of the
letter "x".
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
944 x 250
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Wyeth LLC
*STREET
235 East 42nd Street
*CITY
New York
*STATE
(Required for U.S. applicants)
New York
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10017
PHONE
212-733-9778
FAX
212-573-2273
EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.pfizer.com
LEGAL ENTITY INFORMATION
*TYPE
LIMITED LIABILITY COMPANY
* STATE/COUNTRY WHERE LEGALLY ORGANIZED
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Antifungal preparations; Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis;
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal,
metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical
preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Smoking cessation preparations; Human vaccine
preparations; Pharmaceutical preparations for use in dermatology
*FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
ATTORNEY INFORMATION
NAME
Janina Gorbach
ATTORNEY DOCKET NUMBER
T426786
FIRM NAME
Pfizer Inc.
STREET
235 East 42nd Street
CITY
New York
STATE
New York
COUNTRY
United States
ZIP/POSTAL CODE
10017
PHONE
212-733-9778
FAX
212-573-2273
EMAIL ADDRESS
deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Tiffany Trunko, Richard A. Friedman, Heather McDonald, Seana Smith
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88369665
Filing Date:04/03/2019
To the Commissioner for Trademarks:
MARK: VYNDAMAX (stylized and/or with design, see mark)
The mark in your application is VYNDAMAX.
The applicant is not claiming color as a feature of the mark. The mark consists of the word "Vyndamax" with three curved lines, each tapering to a point, that form a flare design above and to the
right of the letter "x".
The applicant, Wyeth LLC, a limited liability company legally organized under the laws of Delaware, having an address of
235 East 42nd Street
New York, New York 10017
United States
212-733-9778(phone)
212-573-2273(fax)
XXXX (not authorized)
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Antifungal preparations; Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis;
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal,
metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical
preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Smoking cessation preparations; Human vaccine preparations;
Pharmaceutical preparations for use in dermatology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For informational purposes only, applicant's website address is: www.pfizer.com
The applicant's current Attorney Information:
Janina Gorbach and Tiffany Trunko, Richard A. Friedman, Heather McDonald, Seana Smith of Pfizer Inc. 235 East 42nd Street
New York, New York 10017
United States
212-733-9778(phone)
212-573-2273(fax)
deadlinesipnyo@pfizer.com (authorized)
The attorney docket/reference number is T426786.
The applicant's current Correspondence Information:
Janina Gorbach
Pfizer Inc.
235 East 42nd Street
New York, New York 10017
212-733-9778(phone)
212-573-2273(fax)
deadlinesipnyo@pfizer.com;deborah.melita@pfizer.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Janina Gorbach/ Date: 04/03/2019
Signatory's Name: Janina Gorbach
Signatory's Position: Corporate Counsel, New York bar member
Signatory's Phone Number: 212-733-9778
Payment Sale Number: 88369665
Payment Accounting Date: 04/04/2019
Serial Number: 88369665
Internet Transmission Date: Wed Apr 03 15:14:43 EDT 2019
TEAS Stamp: USPTO/FTK-XXX.XXX.XX.XX-2019040315144363
4421-88369665-620b82311792b392d96c09d1e4
4305cb308e0bba317f06c646731d4bfbc822b-DA
-1463-20190403145604382365